
Hyssop Health in the News
Check here frequently for the latest news about Hyssop Health, an all-natural alternative solution for wellness.
Hi-Tech Pharmacal's ECR Subsidiary to Launch a New Dermatitis Treatment |
January 7, 2010
Hi-Tech Pharmacal Co., Inc.
Press Release
AMITYVILLE, N.Y., Jan 07, 2010 (BUSINESS WIRE) -- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that it received clearance from the FDA to market Tropazone(TM) lotion, a prescription dermatological product which will be promoted by Hi-Tech's branded marketing subsidiary, ECR Pharmaceuticals Co., Inc. The product is indicated for the treatment of various dermatological conditions including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis. Tropazone(TM) utilizes patented Lyphazome(TM) technology. This delivery system prolongs product activity while enhancing penetration and hydration of the skin. Tropazone(TM) is patent protected, and two additional patents are pending. Tropazone(TM) will be promoted by ECR's 55 person field force beginning February 2010.
Read more at Hi-Tech Pharmacal Co., Inc.: Hi-Tech Pharmacal's ECR Subsidiary to Launch a New Dermatitis Treatment